City Therapeutics

Drug Discovery · Cambridge, MA · Founded 2024 · Privately Held (backing)

Operator of a biotechnology company intended to develop innovative, precise, and effective treatments for a wide range of diseases. City Therapeutics is based in Cambridge, MA and was founded in 2024. It is valued at about $285 million as of Oct 2026, set by institutional fund marks. It has raised $140 million across 1 recorded round; the latest was a $135 million Series A in Oct 2024.

PMV mark · valuation
$285.5M
Oct 2026
Priced at
its Series A
Oct 2024
Total raised
$139.5M
Last round
Early Stage VC (Series A)
Oct 2024

Who backs City Therapeutics?

8 investors
InvestorType
Fidelity Management & Research CompanyAsset manager
ARCH Venture PartnersVenture capital
The Invus GroupPE / buyout
Rock Springs CapitalHedge fund
Slate Path CapitalHedge fund
AN Ventures—
Altitude Life Science Ventures—
Regeneron Ventures—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

City Therapeutics investors

8 investors are on record for City Therapeutics, including Fidelity Management & Research Company, ARCH Venture Partners, The Invus Group and Rock Springs Capital. The Series A in Oct 2024 drew 7 investors.

Free account
More of City Therapeutics with a free account
  • ·Watch City Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like City Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View